Skip to main content
May 04, 2021
Research expected to be published later this month demonstrated that MDMA brought relief to individuals suffering from post-traumatic stress disorder—a key step to MDMA-assisted therapy receiving FDA approval for the treatment of PTSD—according to a report published Monday by the New York Times.…
April 27, 2021
A recent study to explore the relationship between microdosing, personality change and emotional awareness has found that the consumption of sub-perceptual doses of psychedelic drugs might have an impact on otherwise stable personality traits. The findings were published by the Journal of…
April 15, 2021
A Phase II clinical trial conducted in London found that in a select group of patients, doses of psilocybin produced comparable antidepressant effects as escitalopram, a commonly prescribed medication for the treatment of depression. Findings from the study were published this week in the New…
April 14, 2021
Thanks to $6.4 million in private funding, a new Neuroscape Psychedelics Division has been formed at the University of Califorinia, San Francisco. The division will focus on the delivery of more personalized and precise psychedelic treatments for various mental health conditions. The Neuroscape…
April 12, 2021
A report published by CDC in August 2020 showed huge increases in mental health issues during the time period April-June 2020 compared with the same time period the previous year. Instances of suicidal conditions increased 200%, anxiety disorders 300%, and depression 400%. The report indicates…
March 30, 2021
Research recently published in the journal ACS Pharmacology & Translational Science has identified personality traits that have been associated with positive and negative experiences for patients in psychedelics studies. The findings could help guide practitioners in future studies identify…
March 23, 2021
The University of Wisconsin-Madison on Tuesday announced the launch of a master’s training program in psychedelic science. The program, which will be delivered fully online, is the first of its kind in the U.S.
March 17, 2021
Psychedelics are seeing a resurgence with a growing body of research exploring the potential of psychedelic-assisted therapy for a variety of clinical applications. But while progress around psychedelics has accelerated in a relatively brief period in recent years, their exploration has been a long…
March 16, 2021
Survey respondents who reported having tried a classic psychedelic at least once in their lifetime were found to have significantly more positive replies in three measurements of physical health, according to a study published this month in the Journal of Psychopharmacology.
March 15, 2021
Massachusetts General Hospital recently announced the opening of a new program to study the use of psychedelics to treat mental illnesses, including depression, anxiety and PTSD.
Back to Top